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ttp://dx.doi.org/10.1016/j.jmoldx.2013.10.011Salmonella enterica species infections are a signiﬁcant public health problem causing high morbidity rates
worldwide andhighmortality rates in thedevelopingworld. These infectionsarenot always rapidly diagnosed
as a cause of bloodstream infections because of the limitations of blood culture, which greatly affects clinical
care as a result of treatment delays. A molecular diagnostic assay that could rapidly detect and identify S.
enterica species infections as a causeof sepsis isneeded. Nine typhoidal andnontyphoidalS. enterica serovars
were used to establish the limit of detection (LOD) of a previously published 16S rRNA gene PCR (16S PCR) in
mock whole blood specimens. In addition, 16 typhoidal and nontyphoidal S. enterica serovars were used to
evaluate the serovar differentiation capability of 16S PCR coupled with high-resolution melt analysis. The
overall LODof 16S PCR for the nine typhoidal andnontyphoidal S. enterica serovars analyzedwas<10 colony-
forming units per milliliter (CFU/mL) inmock whole blood specimens, with the lowest and highest LOD at<1
CFU/mL and 9 CFU/mL, respectively. By high-resolution melt analysis, the typhoidal and nontyphoidal
S. enterica serovar groups analyzed each generated a unique grouping code, allowing for serovar-level
identiﬁcation. 16S PCR coupled with high-resolution melt analysis could be a useful molecular diagnostic
that could enhance the current diagnostic, treatment, and surveillance methods of S. enterica bloodstream
infections. (J Mol Diagn 2014, 16: 261e266; http://dx.doi.org/10.1016/j.jmoldx.2013.10.011)Supported by the Middle Atlantic Regional Center of Excellence for
Biodefense and Emerging Infectious Diseases, National Institute of Allergy
and Infectious Diseases/NIH grant U54 AI057168 (R.E.R.).
Disclosures: None declared.Each year in the United States, approximately 1 million
domestically acquired foodborne illnesses and >350 deaths
occur as a result of nontyphoidal Salmonella enterica spe-
cies infections,1,2 whereas worldwide, approximately 93.8
million illnesses and 155,000 deaths occur.2e4 Typhoidal
S. enterica species infections cause approximately 21.7
million cases of typhoid fever and >200,000 deaths annu-
ally worldwide.3,5e7 Typhoidal and nontyphoidal S.stigative Pathology
.enterica species infections are a signiﬁcant public health
problem, causing high worldwide morbidity rates and high
mortality rates in the developing world.1e7
Table 1 LOD of 16S PCR for S. enterica Species Detection
Species Serovar LOD (CFU/mL)
Typhoidal
S. enterica serovar Typhi CVD A19 9
S. enterica serovar Paratyphi A EAR 6473 9
S. enterica serovar Paratyphi B VSM 6217 5
S. enterica serovar Paratyphi C CVD P53 <1
Nontyphoidal
S. enterica serovar Typhimurium CVD A13 4
S. enterica serovar Enteritidis CVD J73 2
S. enterica serovar Dublin CVD R17 1
S. enterica serovar Choleraesuis
variant Kunzendorf
P159 <1
S. enterica serovar Newport 361 <1
Masek et alAlthough S. enterica species infections are seen as a
signiﬁcant public health problem, the global burden of these
infections is poorly characterized due, in part, to insufﬁcient
diagnostic and surveillance methods and emergence of
antimicrobial-resistant S. enterica species.1e12 The Centers for
Disease Control and Prevention and the World Health Organi-
zation have established laboratory-based surveillance programs
and guidelines for the detection, identiﬁcation, treatment,
and prevention of S. enterica species infections.1e4,9,10,12e15
However, not all S. enterica species infections are properly
diagnosed, leading to delays in adequate treatment and ac-
curate surveillance data, further complicating S. enterica
burden.1,3e6,8,12
The diagnosis of an S. enterica species infection requires
isolationof theorganismfromfeces, blood, or other sterile body
ﬂuid in a clinical laboratory.3,6,8,12 Hospitals or other clinical
settings isolating Salmonella from clinical specimens are
required to send isolates to a public health laboratory for further
identiﬁcation via serotyping.2,9,12 Overall, the organism iden-
tiﬁcation process can take several days, negatively affecting
timely clinical treatment decisions, as well as surveillance
data.8,12 There are reports of molecular methods that have been
developed to detect S. enterica species infections.16e23 How-
ever, there are no rapid identiﬁcationmethods for the diagnosis
of S. enterica species from human clinical specimens approved
by the US Food and Drug Administration.3,6,8,12
There is a need to develop a sensitive and speciﬁc assay for
rapid detection and identiﬁcation of S. enterica species in-
fections; such an assay would greatly enhance the current
diagnostic, treatment, and surveillance methods associated
with this global public health problem. Use of a molecular
diagnostic for rapid and accurate detection and identiﬁcation of
S. enterica species in a clinical matrix would be an ideal
adjunctive to the gold standard of microbiological culture. A
rapid molecular diagnostic that could accurately detect and
differentiate S. enterica serovars would aid patient care, espe-
cially in cases of bloodstream infections. Emergency care de-
cision making, and improved clinical outcomes by increasing
timeliness to appropriate treatment and accurate surveillance
data, would also be aided by improved diagnostics.
The purpose of this study was to determine the limit of
detection (LOD) in mock whole blood specimens and the
serovar differentiation capability of a broad-based 16S rRNA
genePCR(16SPCR)coupledwithhigh-resolutionmelt analysis
(HRMA) for typhoidal and nontyphoidal S. enterica species.
Materials and Methods
Salmonella Species
Nine typhoidal and nontyphoidal S. enterica serovars (Table 1),
obtained from the Center for Vaccine Development (CVD;
University of Maryland School of Medicine, Baltimore, MD),
were used to establish the LOD of a previously described
broad-based 16S PCR.24,25 Each S. enterica serovar was grown
in Trypticase SoyBroth (TSB; BectonDickinson, Sparks,MD)262at 37C with continuous mixing on a platform rocker for 12 to
16 hours. At the end of the incubation period, the concentration
of each S. enterica serovar was estimated to be approximately
108 colony-forming units permilliliter (CFU/mL) in TSB using
McFarland Equivalence Turbidity Standard (Remel; Thermo
Fisher Scientiﬁc, Lenexa, KS).
Sixteen typhoidal and nontyphoidal S. enterica serovars
(Table 2), composed of nine groups of species, obtained
from CVD were used to evaluate the serovar differentiation
capability of the previously described broad-based 16S PCR
coupled with HRMA.26e28 Each S. enterica serovar was
grown in TSB at 37C with continuous mixing on a plat-
form rocker for 12 to16 hours.
All serovars acquired from CVD were well-characterized
clinical isolates that were established to be members of their
respective serovars (eg, Typhi and Paratyphi A to C) and
nontyphoidal serovars (eg, Typhimurium and Enteritidis).
These organisms were chosen for analysis because of avail-
ability and because they were representative of different
types of S. enterica that are commonly observed clinically.
Serial Dilutions and Mock Whole Blood Specimens
Ten 10-fold serial dilutions of each 108 CFU/mL S. enterica
serovar stock organism were generated using 3 mL of auto-
claved, ﬁltered (Corning Inc., Corning, NY) nuclease-free
water (Ambion, Life Technologies, Grand Island, NY).
Mock whole blood specimens were generated from each 10-
fold serial dilution by the addition of 5 mL of human whole
blood [human whole blood K2EDTA, unspun and tested
negative (hepatitis B surface antigen, rapid plasma reagin,
antibodies to HIV and hepatitis C virus, nonreactive HIV-1
and hepatitis C virus RNA)] (Biological Specialty Corpora-
tion, Colmar, PA). Eachmockwhole blood specimen (nZ 90)
was made to a total volume of 8 mL, of which 5 mL was used
for nucleic acid extraction.
Titer Determination
For each S. enterica serovar, 100 mL of each mock whole
blood specimen, ranging from 1:106 to 1:109 dilution, wasjmd.amjpathol.org - The Journal of Molecular Diagnostics
Table 2 Unique Grouping Codes Generated by HRMA for S.
enterica Species
Organism
Grouping codes
V1 V3 V6
Typhoidal
S. enterica Typhi (2) d a d
S. enterica Paratyphi A (2) k e l
S. enterica Paratyphi B (2) d e l
S. enterica Paratyphi C k a l
Nontyphoidal
S. enterica Typhimurium (2) d b d
S. enterica Enteritidis (2) a a g
S. enterica Dublin (2) k e h
S. enterica Choleraesuis (2) k a i
S. enterica Newport d e m
Parentheses indicate serovars evaluated for each S. enterica species.
HRMA Differentiation of S. entericaplated to determine colony count on Trypticase Soy Agar
with 5% Sheep Blood (TSA blood agar plate; Becton Dick-
inson, Sparks, MD) and incubated overnight at 37C. For
each S. enterica serovar, 1000 mL of the 1:1010 mock whole
blood specimen dilution was plated onto 10 different TSA
blood agar plates, in 100-mL volumes, and incubated over-
night at 37C. These 14 TSA blood agar plates were used to
determine titer in terms of CFU/mL for each S. enterica
serovar. The titer obtained for each S. enterica serovar was
used to determine the LOD of 16S PCR in terms of CFU/mL.Nucleic Acid Extraction
Nucleic acid was extracted from the mock whole blood
specimens generated for each S. enterica serovar using Mol-
zym’s MolYsis Basic 5, 5 mL whole blood (Molzym GmbH
and Co KG, Bremen, Germany), according to the manufac-
turer’s instructions, with the following modiﬁcations that were
in combination with our in-house nucleic acid extraction
method.24e26 Bacterial cells were harvested with centrifuga-
tion of 2100  g for 20 minutes. Bacterial cell pellets were
resuspended with 100 mL of autoclaved, ﬁltered, and DNase I
(Ambion, Life Technologies) treated nuclease-free water. This
was followed by the addition of 60 mL of bacterial lysis buffer
(MagNA Pure Bacteria Lysis Buffer; Roche Diagnostics,
Indianapolis, IN), 10 mL of 0.5 mg/mL lysostaphin (Sigma-
Aldrich, St. Louis, MO), and 10 mL of 0.32 mg/mL lysozyme
(Sigma-Aldrich). Specimens were vortexmixed and incubated
in a heat block at 37C for 30 minutes. Proteinase K at 20 mg/
mL (20 mL; MagNA Pure LC Proteinase K; Roche Di-
agnostics) was added, and specimens were vortex mixed and
incubated in a heat block at 65C for 10 minutes. Specimens
were vortex mixed and placed at 80C for 10 minutes and
then at 95C for 5minutes before a ﬁnal nucleic acid extraction
using the MagNA Pure LCeDNA Isolation Kit I (Roche Di-
agnostics), as per the manufacturer’s instructions. Positive and
negative control specimens were extracted along with the
mock whole blood specimens for quality control purposes.The Journal of Molecular Diagnostics - jmd.amjpathol.orgNucleic acid was extracted from each of the 16 S. enterica
serovar specimens using theMagNA Pure LCeDNA Isolation
Kit I, according to the manufacturer’s instructions. Positive
and negative control specimens were extracted along with the
S. enterica serovar specimens for quality control purposes.
Primer Design and Sequence Analysis
Primers used for 16S PCR and HRMA analysis were
designed as described.24e28 For HRMA analysis, typhoidal
and nontyphoidal S. enterica species sequences for potential
PCR products generated by the V1, V3, and V6 primers
were analyzed using BioEdit (Ibis Biosciences, Carlsbad,
CA) to determine whether sequence differences between
different species of S. enterica were substantial enough for
differentiation with HRMA. From this analysis, it was
determined that using a single set of primers for the V1, V3,
or V6 regions alone would be insufﬁcient to differentiate the
S. enterica species, and that primers for all three regions
would be required to provide unique identiﬁcation codes for
typhoidal and nontyphoidal S. enterica species.
16S PCR and HRMA
Extracted whole blood specimens from each S. enterica
serovar were tested for the presence of eubacterial DNA by
16S PCR, using universal primers and uniprobe, as previ-
ously described.24,25 Positive and negative controls were
included for quality control purposes and for negative cutoff
determination. Both specimens and controls were analyzed in
triplicate. Brieﬂy, 16S PCR was performed with primers
p891F (50-TGGAGCATGTGGTTTAATTCGA-30) and
p1033R (50-TGCGGGACTTAACCCAACA-30) in a total
volume of 50 mL, which comprised 30 mL of PCRmaster mix
and 20 mL of sample input. PCR master mix contained 25 mL
of 2 TaqMan Universal PCR Master Mix (Applied Bio-
systems, Foster City, CA) and 1.5 mL of 67 mmol/L forward
primer and reverse primer. The 2 TaqMan universal PCR
master mix and the primers underwent an ultraﬁltration step,
as previously described.24,25 After ultraﬁltration, 1 mL of 2.5
U of AmpliTaq Gold LD (Applied Biosystems) and 1 mL of
10 mmol/L probe were added to make up the ﬁnal master mix
before sample addition. PCR conditions were performed as
previously described.24,25
For serovar differentiation, 16SPCRwasused, as previously
described,24,25 to determine the presence of eubacterialDNA in
each S. enterica serovar specimen. After 16S PCR, each S.
enterica serovar specimen that tested positive for eubacterial
DNA by 16S PCR was analyzed using HRMA, as previously
described,26e28 for serovar identiﬁcation. Salmonella enterica
serovar specimens, along with appropriate control specimens
for each of the nine different serovar groups, were assayed in
triplicate for each hypervariable region: V1, V3, and V6.
Brieﬂy, every HRMA analysis was performed in a 10 mL total
volume composed of 8 mL of PCR master mix and 2 mL
of target input. The PCR master mix contained 4 mL of263
Masek et al2.5 LightScanner Master Mix (Idaho Technology, Salt Lake
City, UT) and 2 mL of LightScanner Reagent Grade water
(Idaho Technology). A total of 1 mL of 1.5 mmol/L forward
primer and reverse primer forV1,V3, andV6 regions26e28was
added to each separate reaction. Each PCR analysis contained
one primer pair. The PCR was performed using reaction con-
ditions as previously described.26e28
Data Analysis for LOD and Serovar Differentiation
For LOD determination, 16S PCRepositive results were
deﬁned as reactions having a CT value <32. This CT cutoff
was determined by the appropriate negative controls and an
exponential increase in ﬂuorescence above baseline. Positive
ampliﬁcation was conﬁrmed through analysis of multicom-
ponent data. A positive 16S PCR result indicated the pres-
ence of eubacterial DNA in the nucleic acid extracted from
the specimen. The LOD, calculated as CFU/mL, for each
S. enterica serovar was determined using the 16S PCR results
and calculated concentrations from plate titers.
For serovar differentiation via HRMA, 16S PCRepositive
results were deﬁned as reactions having a CT value<32. This
CT cutoff was determined as previously described. A positive
16S PCR result indicated the presence of eubacterial DNA in
the nucleic acid extracted from the S. enterica serovar spec-
imen. For HRMA, positive results were deﬁned as specimens
havingmelt curve proﬁles that matched control organismmelt
curve proﬁles.26e28 Brieﬂy, HRMA was performed on the
LightScanner instrument (Idaho Technology) using a tem-
perature gradient from 60C to 95C, with data acquisition
performed for every 0.1C increase in temperature. Light-
Scanner Software version 2.0 (Idaho Technology), was used
for data analysis, and the negative ﬁlter was ﬁrst used to
identify negative controls and any failed PCRs, followed by
ﬂuorescence normalization to minimize the variations in
ﬂuorescence magnitude between samples due to differences
in starting template concentration. Derivative plots were
generated to assess the number of melting peaks. Analysis
subsets (V1, V3, andV6) were deﬁned by the primer sets used
for ampliﬁcation. Difference plots were then generated using
the autogrouping software feature to group all positive sam-
ples with a similar curve shape within the same analysis
subset. A unique letter code was manually assigned for each
group identiﬁed, starting with the letter a and progressing
alphabetically. A combination of each letter from each of the
variable regions was then accumulated to provide a signature
code for each organism. Initial validation for Salmonella was
performed previously27 with one organism, and this study
expanded this ﬁnding to increase the differentiation capability
and speciﬁcity of HRMA for S. enterica species.
Results
The LOD for each individual S. enterica serovar mock
whole blood specimen analyzed by 16S PCR is shown in
Table 1. The overall LOD of 16S PCR for all nine typhoidal264and nontyphoidal S. enterica serovars analyzed was <10
CFU/mL. The S. enterica serovars with the lowest LOD (<1
CFU/mL) are S. enterica serovar Paratyphi C, CVD P53;
S. enterica serovar Choleraesuis variant Kunzendorf, P159;
and S. enterica serovar Newport, 361. The S. enterica
serovars with the highest LOD (9 CFU/mL) are S. enterica
serovar Typhi, CVD A19; and S. enterica serovar Paratyphi
A, EAR 6473.
All 16 typhoidal and nontyphoidal S. enterica serovars in
the nine species groups tested positive for eubacterial DNA
by 16S PCR. The S. enterica serovar specimens testing
positive for eubacterial DNA were then analyzed by HRMA.
Specimens from each of the nine groups of S. enterica
serovars generated unique grouping codes when analyzed by
HRMA (Table 2).
Discussion
In this study, the analytical sensitivities of a previously
described broad-based 16S PCR24,25 are reported for nine
typhoidal and nontyphoidal S. enterica serovars (Table 1)
in mock whole blood specimens. The overall analytical
sensitivity reported, <10 CFU/mL for all serovars evalu-
ated, is within the lower limits of clinically relevant
concentrations of S. enterica infections. These analytical
sensitivities, albeit generated by mock whole blood speci-
mens, might have potential clinical utility in direct testing
of blood samples from patients with suspected S. enterica
infections. However, this practical utility needs to be
evaluated by a clinical test trial.
In addition to evaluating the analytical sensitivities, the
serovar differentiation capability of the 16S PCR coupled
with HRMA26e28 for 16 typhoidal and nontyphoidal S.
enterica organisms, making up nine different serovar groups,
was analyzed in this study. The grouping codes generated by
the analysis of these serovars using 16S PCR coupled with
HRMA (Table 2) demonstrated that each of the nine S.
enterica serovar groups analyzed generated unique grouping
codes. These unique grouping codes enable serovar-level
differentiation between all nine of the S. enterica serovar
groups. The data generated by HRMA were highly similar to
what were observed by performing sequence analysis, and
conﬁrmed the need to use primers for V1, V3, and V6 regions
of the 16S rRNA gene to generate unique grouping codes for
all S. enterica serovars analyzed. For example, S. enterica
Typhi, Paratyphi B, Typhimurium, and Newport all produced
the same melting curve for the V1 region of the 16S rRNA
gene, consistent with observations from sequence analysis of
that region.
The level of identiﬁcation achieved by the 16S PCR
coupled with HRMA could be considered comparable to that
of serotyping performed by public health laboratories. Other
methods that could be used for species differentiation of
S. enterica responsible for an infection would include mul-
tilocus sequence typing, matrix-assisted laser desorption/
ionization time of ﬂight (MALDI-TOF), or next-generationjmd.amjpathol.org - The Journal of Molecular Diagnostics
HRMA Differentiation of S. entericasequencing. These methods of species-level identiﬁcation
have some advantages over using HRMA for species-level
identiﬁcation. MALDI-TOF has been successfully used for
rapid discrimination of S. enterica serovar Typhi from non-
typhoidal serovars; however, this was performed from posi-
tive blood culture specimens, adding delays because of the
culture process, as opposed to detecting the organism directly
from patient blood specimens.23 Next-generation sequencing
is certainly more informational than MALDI-TOF or HRMA
for species-level identiﬁcation, but the time and technical
requirements for these methods can limit their applicability in
clinical settings, or settings where treatment decisions are
required in a timely manner. HRMA has a simpler testing
format than many molecular methods, is substantially faster
than blood culture and other techniques, is a closed-tube
system, and has the capability to provide identiﬁcation of
pathogenic organisms directly from human clinical speci-
mens.29 Although HRMA has disadvantages, notably the
inability to resolve specimens with polymicrobial infections
or high levels of contaminating DNA sequences, it poten-
tially offers diagnostic information that would allow for
timely, accurate results that would improve diagnosis and
treatment of serious S. enterica bloodstream infections.
The broad-based 16S PCR assay demonstrated excellent
analytical sensitivity for detecting nine common serovars of
typhoidal and nontyphoidal S. enterica from mock whole
blood specimens, whereas the HRMA component of the
assay illustrated accurate differentiation of nine S. enterica
serovar groups. Detection of these emerging pathogens in
febrile, clinically ill patients will be required in future
studies to determine the true clinical utility of this molecular
diagnostic method for the diagnosis and surveillance of S.
enterica species infections.Acknowledgments
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